1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SH2D3A CTRPv2 pan-cancer AAC 0.1 0.01
mRNA PAWR CTRPv2 pan-cancer AAC -0.1 0.01
mRNA ZNF563 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA MAML3 CTRPv2 pan-cancer AAC 0.099 0.01
mRNA MGARP CTRPv2 pan-cancer AAC -0.091 0.01
mRNA FAM72C CTRPv2 pan-cancer AAC -0.1 0.01
mRNA NOC3L CTRPv2 pan-cancer AAC -0.088 0.01
mRNA ROCK1 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA CXCL17 CTRPv2 pan-cancer AAC 0.086 0.01
mRNA LARP1 CTRPv2 pan-cancer AAC -0.089 0.01
Download CSV